Melanotan I and Melanotan II linked to rapidly changing moles

Melanotan (an unlicensed medicine dubbed the "tan jab") can cause rapid changes in the appearance of moles, warn skin experts in this week's BMJ.

There are two types of Melanotan – Melanotan I and Melanotan II. They work by increasing the levels of melanin (the body's natural pigment that protects us from the sun) resulting in a suntan.

Melanotan has not been tested by the medicines regulator, but both products are being advertised and sold illegally as an injectable tan on the internet and in some tanning salons and body building gyms.

The authors describe two patients attending their dermatology clinic with rapidly changing moles and an intense tan, despite their fair skin type. They were both sunbed users and both had injected Melanotan I and II, bought from the internet, shortly before their moles changed.

The Medicines and Healthcare products Regulatory Agency (MRHA) recently raised concerns about the health risks of these counterfeit drugs, say the authors. These cases highlight a further area of concern – changes in the appearance of existing moles.

They warn that unregulated use of Melanotan may lead to an increase in the number of patients seeking medical advice about changing moles and may even confuse the diagnosis. They suggest healthcare professionals look out for unexpected tanning as a clue to such use.

Comments

  1. sunless tanning sunless tanning Philippines says:

    Maybe the illegal melanotan injections are responsible for the rapid changing of moles in the body. So the authority must be more vigilant in removing this in the market.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers uncover the potential of JAK inhibitors to treat life-threatening skin disease